advertisement

Topcon

Fuchshofer R 11

Showing records 1 to 11 | Display all abstracts from Fuchshofer R

107691 Enhanced glaucomatous damage accompanied by glial response in a new multifactorial mouse model
Reinehr S
Frontiers in immunology 2022; 13: 1017076
108689 CCN2/CTGF tip the balance of growth factors towards TGF-β2 in primary open-angle glaucoma
Dillinger AE; Kuespert S
Frontiers in molecular biosciences 2023; 10: 1045411
107691 Enhanced glaucomatous damage accompanied by glial response in a new multifactorial mouse model
Girbig RM
Frontiers in immunology 2022; 13: 1017076
108689 CCN2/CTGF tip the balance of growth factors towards TGF-β2 in primary open-angle glaucoma
Seleem AA
Frontiers in molecular biosciences 2023; 10: 1045411
107691 Enhanced glaucomatous damage accompanied by glial response in a new multifactorial mouse model
Schulte KK
Frontiers in immunology 2022; 13: 1017076
108689 CCN2/CTGF tip the balance of growth factors towards TGF-β2 in primary open-angle glaucoma
Neuendorf J
Frontiers in molecular biosciences 2023; 10: 1045411
107691 Enhanced glaucomatous damage accompanied by glial response in a new multifactorial mouse model
Theile J; Asaad MA
Frontiers in immunology 2022; 13: 1017076
108689 CCN2/CTGF tip the balance of growth factors towards TGF-β2 in primary open-angle glaucoma
Schneider M
Frontiers in molecular biosciences 2023; 10: 1045411
107691 Enhanced glaucomatous damage accompanied by glial response in a new multifactorial mouse model
Fuchshofer R
Frontiers in immunology 2022; 13: 1017076
108689 CCN2/CTGF tip the balance of growth factors towards TGF-β2 in primary open-angle glaucoma
Fuchshofer R
Frontiers in molecular biosciences 2023; 10: 1045411
107691 Enhanced glaucomatous damage accompanied by glial response in a new multifactorial mouse model
Dick HB; Joachim SC
Frontiers in immunology 2022; 13: 1017076

Issue 23-4

Change Issue


advertisement

Nidek